Table 3.

Sensitivity analysis of the relationship between the TyG index and cardiovascular events stratified by diabetes status and successful or failed CTO PCI

	T1		T2		T3
	HR (95%CI)	P value	HR (95%CI)	P value	HR (95%CI)	P value
DM#	1 (reference)	0.356	1.81 (0.68–4.86)	0.237	2.11 (0.74–5.98)	0.162
Non-DM#	1 (reference)	0.040	1.01 (0.41–2.51)	0.979	2.35 (1.06–5.20)	0.036
Successful CTO PCI*	1 (reference)	0.013	1.33 (0.58–0.04)	0.495	2.69 (1.29–5.60)	0.008
Failed CTO PCI*	1 (reference)	0.373	0.52 (0.15–1.79)	0.299	1.32 (0.37–4.67)	0.672

^#Adjusted for age, sex, BMI, current smoker, hypertension, dyslipidemia, previous PCI, previous CABG, AMI, FBG, TC, LDL-C, using of statin, ezetimibe, or antidiabetic medication, successful CTO PCI. TyG index Tertiles in diabetes mellitus patients: T1: ≤ 8.65, T2: > 8.65, ≤ 9.26, T3: > 9.26; TyG index Tertiles in non-diabetes mellitus patients: T1: ≤ 8.43, T2: > 8.43, ≤ 8.83, T3: > 8.83

^*Adjusted for age, sex, BMI, current smoker, hypertension, DM, dyslipidemia, previous PCI, previous CABG, AMI, FBG, TC, LDL-C, using of statin, ezetimibe, or antidiabetic medication. TyG index Tertiles in successful CTO PCI patients: T1: ≤ 8.50, T2: > 8.50, ≤ 8.96, T3: > 8.96; TyG index Tertiles in failed CTO PCI patients: T1: ≤ 8.53, T2: > 8.53, ≤ 8.91, T3: > 8.91